2348.HK Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 09:07):

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally...

Stats
Tagesvolumen	116 000
Durchschnittsvolumen	286 540
Marktkapitalisierung	1.79B
EPS	HKD0 ( 2023-08-25 )
Nächstes Ertragsdatum	( HKD0 ) 2024-05-24
Last Dividend	HKD0.0150 ( 2023-09-19 )
Next Dividend	HKD0 ( N/A )
P/E	5.17
ATR14	HKD0 (0.00%)

Dawnrays Pharmaceutical Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Dawnrays Pharmaceutical Finanzdaten

Annual	2023
Umsatz:	HKD1.15B
Bruttogewinn:	HKD641.52M (55.73 %)
EPS:	HKD0.220

FY	2023
Umsatz:	HKD1.15B
Bruttogewinn:	HKD641.52M (55.73 %)
EPS:	HKD0.220

FY	2022
Umsatz:	HKD1.28B
Bruttogewinn:	HKD766.68M (60.01 %)
EPS:	HKD0.240

FY	2021
Umsatz:	HKD1.17B
Bruttogewinn:	HKD681.26M (58.47 %)
EPS:	HKD0.230

Financial Reports:

No articles found.

Dawnrays Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.0150 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.0730 (N/A)	HKD0.0150 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Dawnrays Pharmaceutical Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.88 - good (98.76%) | Divividend Growth Potential Score: 6.07 - Stable (21.38%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.00750	2003-10-17
Last Dividend	HKD0.0150	2023-09-19
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	40	--
Total Paid Out	HKD0.998	--
Avg. Dividend % Per Year	0.00%	--
Score	3.29	--
Div. Sustainability Score	9.88
Div.Growth Potential Score	6.07
Div. Directional Score	7.97	--

Next Divdend (Est)
(2024-07-03)

HKD0.0131 Estimate 12.35 %

Dividend Stability

0.49 Below Average

Dividend Score

3.29

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6117.HK	Ex Dividend Junior	2023-05-22	Sporadic	0.00%
1857.HK	Ex Dividend Junior	2023-08-23	Semi-Annually	0.00%
0881.HK	Ex Dividend Junior	2023-06-23	Annually	0.00%
0026.HK	Ex Dividend Junior	2023-10-03	Semi-Annually	0.00%
2669.HK	Ex Dividend Knight	2023-06-23	Semi-Annually	0.00%
1428.HK	Ex Dividend Knight	2023-08-23	Annually	0.00%
0518.HK	Ex Dividend Junior	2023-09-01	Sporadic	0.00%
6869.HK	Ex Dividend Junior	2023-07-04	Annually	0.00%
1977.HK	Ex Dividend Knight	2023-09-11	Semi-Annually	0.00%
1036.HK	Ex Dividend Junior	2023-06-21	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.283	1.500	4.34	6.50	[0 - 0.5]
returnOnAssetsTTM	0.0900	1.200	7.00	8.40	[0 - 0.3]
returnOnEquityTTM	0.115	1.500	9.83	10.00	[0.1 - 1]
payoutRatioTTM	0.359	-1.000	6.41	-6.41	[0 - 1]
currentRatioTTM	2.57	0.800	2.14	1.714	[1 - 3]
quickRatioTTM	2.08	0.800	2.49	1.995	[0.8 - 2.5]
cashRatioTTM	1.354	1.500	3.59	5.38	[0.2 - 2]
debtRatioTTM	0.0333	-1.500	9.45	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.226	2.00	9.92	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0926	2.00	9.95	10.00	[0 - 20]
debtEquityRatioTTM	0.0422	-1.500	9.83	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.546	1.000	4.23	4.23	[0.2 - 0.8]
operatingProfitMarginTTM	0.240	1.000	7.20	7.20	[0.1 - 0.6]
cashFlowToDebtRatioTTM	2.81	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.318	0.800	-1.215	-0.972	[0.5 - 2]
Total Score				9.88

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	5.11	1.000	9.58	0	[1 - 100]
returnOnEquityTTM	0.115	2.50	9.89	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0926	2.00	9.97	10.00	[0 - 30]
dividendYielPercentageTTM	7.93	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.226	2.00	9.92	10.00	[0 - 30]
payoutRatioTTM	0.359	1.500	6.41	-6.41	[0 - 1]
pegRatioTTM	0.134	1.500	-2.44	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.294	1.000	5.15	0	[0.1 - 0.5]
Total Score				6.07

Dawnrays Pharmaceutical

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.